| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 3.197 | 36.208 | 37.814 |
| Total Income - EUR | - | - | - | - | - | - | - | 3.209 | 56.919 | 38.712 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 1.838 | 29.522 | 31.123 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 1.371 | 27.398 | 7.589 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 1.339 | 27.058 | 7.210 |
| Employees | - | - | - | - | - | - | - | 1 | 2 | 2 |
Check the financial reports for the company - Valoanamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 793 | 592 |
| Current Assets | - | - | - | - | - | - | - | 3.333 | 27.338 | 8.403 |
| Inventories | - | - | - | - | - | - | - | 125 | 1.817 | 0 |
| Receivables | - | - | - | - | - | - | - | 158 | 2.653 | 106 |
| Cash | - | - | - | - | - | - | - | 3.050 | 22.868 | 8.297 |
| Shareholders Funds | - | - | - | - | - | - | - | 1.380 | 27.107 | 7.258 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 1.954 | 1.024 | 1.737 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Valoanamed S.r.l.